The predictive value of glycated albumin and hemoglobin A1c for all-cause and cardiovascular mortality in chronic kidney disease patients
Diabetol Metab Syndr. 2026 Jan 24. doi: 10.1186/s13098-025-02067-y. Online ahead of print.ABSTRACTBACKGROUND: The reliability of hemoglobin A1c (HbA1c) as a glycemic marker is limited in chronic kidney disease (CKD), which has led to increased interest in glycated albumin (GA). This study aimed to c

